Omicron: US drops in-person interviews for H-1B, other visas for a year

Appointments were being granted months after application due to the pandemic

The United States will allow its consular officers to waive in-person interviews for H-1B and other certain non-immigrant visa applicants through next year to help reduce visa wait times, the State Department said on Thursday.

"The Covid-19 pandemic resulted in profound reductions in the department’s visa processing capacity," it said in a statement. " As global travel rebounds, we are taking these temporary steps to further our commitment to safely and efficiently reduce visa wait times while maintaining national security as our priority."

The consular officers will now be temporarily authorised to waive in-person interviews for nearly a dozen visa categories, including Persons in Specialty Occupations (H-1B visas), visas for students, temporary agricultural and non-agricultural workers, student exchange visitors, as well as athletes, artists and entertainers.

NEW RULES

• Consular officers will now be temporarily authorized to waive in-person interviews for nearly a dozen visa categories
• State Dept has extended indefinitely the authorization to waive the in-person interview for applicants renewing a visa

State Department also said it has extended indefinitely the authorization to waive the in-person interview for applicants renewing a visa in the same visa class within 48 months of the prior visa’s expiration.

US State Department in March 2020 had suspended all routine visa services in most countries worldwide due to the coronavirus outbreak. 

While the services have been reinstated with a limited capacity and on a priority basis, months-long wait times for certain visa appointments persist due to a massive backlog.

1 in 10 Londoners infected: Johnson

Boris Johnson urged Britons to take care at Christmas as he considers whether to tighten pandemic regulations, as government data indicated about 10 per cent of Londoners were infected with Covid-19.

An estimated 1 in 25 people across England -- more than 2 million people -- had coronavirus on Dec 19, according to Office for National Statistics modeling released Friday that also showed about 1 in 10 Londoners were infected as the fast-spreading omicron variant takes hold. A record 119,789 new confirmed Covid-19 cases were logged Thursday, while minutes of a meeting of Johnson’s scientific advisers said omicron hospitalisations are doubling every 4 to 5 days.

US clears Merck pill with riders

Merck’s Covid-19 pill was cleared by US regulators, giving high-risk patients another at-home treatment option at a time when the omicron variant is causing cases to surge. The drug, molnupiravir, received emergency authorisation on the heels of Pfizer Inc.’s competing pill that was cleared Wednesday, Paxlovid. Together, the treatments promise to provide a new way to keep a sharp rise in infections from overwhelming US hospitals.